Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33957
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Crosswell, Howland E | - |
dc.contributor.author | LaCasce, Ann S | - |
dc.contributor.author | Bartlett, Nancy L | - |
dc.contributor.author | Straus, David J | - |
dc.contributor.author | Savage, Kerry J | - |
dc.contributor.author | Zinzani, Pier Luigi | - |
dc.contributor.author | Collins, Graham P | - |
dc.contributor.author | Fanale, Michelle | - |
dc.contributor.author | Fenton, Keenan | - |
dc.contributor.author | Dong, Cassie | - |
dc.contributor.author | Miao, Harry | - |
dc.contributor.author | Grigg, Andrew P | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-10-11T06:21:18Z | - |
dc.date.available | 2023-10-11T06:21:18Z | - |
dc.date.issued | 2023-10-05 | - |
dc.identifier.citation | Haematologica 2023-10-05 | en_US |
dc.identifier.issn | 1592-8721 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/33957 | - |
dc.description.abstract | Not available. | en_US |
dc.language.iso | eng | - |
dc.title | Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Haematologica | en_US |
dc.identifier.affiliation | Bon Secours Hematology and Oncology, Bon Secours, St. Francis Health System, Greenville, SC. | en_US |
dc.identifier.affiliation | Dana-Farber Cancer Institute, Partners Cancer Care, Boston, MA. | en_US |
dc.identifier.affiliation | Siteman Cancer Center, Washington University School of Medicine, St Louis, MO. | en_US |
dc.identifier.affiliation | Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. | en_US |
dc.identifier.affiliation | British Columbia Cancer Agency, Vancouver, BC. | en_US |
dc.identifier.affiliation | IRCCS University Hospital of Bologna, Institute of Hematology "Serà gnoli," Bologna, Italy; Department of Specialized Medicine, Diagnostic and Experimental, University of Bologna, Bologna. | en_US |
dc.identifier.affiliation | Oxford University Hospitals NHS Foundation Trust, Oxford. | en_US |
dc.identifier.affiliation | Seagen Inc., Bothell, WA. | en_US |
dc.identifier.affiliation | Takeda Development Center Americas, Inc. (TDCA), Lexington, MA. | en_US |
dc.identifier.affiliation | Clinical Haematology | en_US |
dc.identifier.doi | 10.3324/haematol.2023.283303 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 37794803 | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Clinical Haematology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.